Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease
Open Access
- 18 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2), e89041
- https://doi.org/10.1371/journal.pone.0089041
Abstract
Peripheral blood Apolipoprotein E (ApoE) levels have been proposed as biomarkers of Alzheimer’s disease (AD), but previous studies on levels of ApoE in blood remain inconsistent. This meta-analysis was designed to re-examine the potential role of peripheral ApoE in AD diagnosis and its potential value as a candidate biomarker. We conducted a systematic literature search of MEDLINE, EMBASE, the Cochrane library, and BIOSIS previews for case-control studies measuring ApoE levels in serum or plasma from AD subjects and healthy controls. The pooled weighted mean difference (WMD) and 95% confidence interval (CI) were used to estimate the association between ApoE levels and AD risk. Eight studies with a total of 2250 controls and 1498 AD cases were identified and analyzed. The pooled WMD from a random-effect model of AD participants compared with the healthy controls was −5.59 mg/l (95% CI: [−8.12, −3.06]). The overall pattern in WMD was not varied by characteristics of study, including age, country, assay method, publication year, and sample type. Our meta-analysis supports a lowered level of blood ApoE in AD patients, and indicates its potential value as an important risk factor for AD. Further investigation employing standardized assay for ApoE measurement are still warranted to uncover the precise role of ApoE in the pathophysiology of AD.This publication has 40 references indexed in Scilit:
- Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer DiseaseArchives of Neurology, 2012
- Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older IndividualsPLOS ONE, 2012
- Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome DatasetPLOS ONE, 2012
- ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse ModelsScience, 2012
- Apolipoprotein E: From lipid transport to neurobiologyProgress in Lipid Research, 2011
- A Serum Protein–Based Algorithm for the Detection of Alzheimer DiseaseArchives of Neurology, 2010
- Blood-based biomarkers of microvascular pathology in Alzheimer’s diseaseExperimental Gerontology, 2010
- Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levelsNeurology, 2009
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Increased plasma apolipoprotein E (apoE) levels in Alzheimer's diseaseNeuroscience Letters, 1997